No Data
The price of Vitamins D3 has surged! The Sector responded with a breakout, and Hunan Er-kang Pharmaceutical hit the 20% limit up.
Institutions: It is expected that the domestic Vitamins share will continue to increase.
A-share afternoon review: Chinext Price Index fell by 0.68%, over 4,100 stocks declined! Electrical Utilities and The Pet Economy Concept rose against the market.
As of the noon close, the Shanghai Composite Index fell 0.1% to 3,292.98 points, the Shenzhen Component Index fell 0.66%, and the Chinext Price Index fell 0.68%.
Hunan Er-Kang Pharmaceutical Co., Ltd's (SZSE:300267) Shareholders Might Be Looking For Exit
Erkang Pharmaceuticals: 2024 Annual Report Summary
Erkang Pharmaceuticals: Report for the first quarter of 2025
Erkang Pharmaceuticals: 2024 Annual Report
Hunan Er-Kang Pharmaceutical (SZSE:300267) Has Debt But No Earnings; Should You Worry?
